This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

5 Stock Insiders are Gobbling Up

Stocks in this article: MACKAVEOAKRXCMLSCPRX

If you're in the bull camp on CMLS, then I would look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $2.73 to $2.90 a share and then once it clears more overhead resistance at $3.12 to $3.13 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 222,979 shares. If that breakout triggers soon, then CMLS will set up to re-test or possibly take out its next major overhead resistance levels at $3.65 to $3.74 a share. Keep in mind that any move above $2.86 will then push CMLS back above its 200-day moving average, which s bullish technical price action.

Catalyst Pharmaceuticals

The last name to consider with some huge insider buying is biotechnology and drugs player Catalyst Pharmaceuticals (CPRX). This company is focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. Insiders are buying this stock into some big time weakness, since shares are off by 65% so far in 2012.

Catalyst Pharmaceuticals has a market cap of $15.06 million and an enterprise value of $3.67 million. This stock trades at a cheap valuation, with a price-to-book of 1.65. Its estimated growth rate for next quarter is 50%, and for this year it's pegged at 31%. This is a cash-rich company, since the total cash position on its balance sheet is $11.97 million and its total debt is zero.

A beneficial owner just bought 5,000,000 shares, or about $3.75 million worth of stock, at 75 cents per share.

From a technical perspective, CPRX is currently trending well below both its 50-day and 200-day moving averages, which is bearish. This stock recently gapped down big from over $1.40 to close to 40 cents per share with heavy downside volume. Following that move, shares of CPRX have been trending sideways between 37 cents on the downside and 54 cents on the upside. A high-volume move outside of that range soon will likely lead to the next major trend for shares of CPRX.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs